Using Mesenchymal Stem Cells to Fill Bone Void Defects in Patients With Benign Bone Lesions

Withdrawn before enrolling · Phase 2/Phase 3

Conditions studied: Bone Neoplasms

In brief

The purpose of this study is to determine whether using mesenchymal stem cells will heal benign bone lesion defects faster than demineralized bone matrix

Key facts

Study ID

NCT00851162

Run by

Emory University

People needed

0

Starts

2009-03-01

Expected to finish

2010-03-01

Last updated by the study team

2012-11-28

Who can join

Age: 11 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ages > 11 years
• Benign bone lesion

You may not qualify if…

• Previous surgery

Where it is running

• Emory University — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.